0001225208-17-000351.txt : 20170104 0001225208-17-000351.hdr.sgml : 20170104 20170104161330 ACCESSION NUMBER: 0001225208-17-000351 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170101 FILED AS OF DATE: 20170104 DATE AS OF CHANGE: 20170104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bose Supratim CENTRAL INDEX KEY: 0001538431 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 17505504 MAIL ADDRESS: STREET 1: 11A COOLING CLOSE CITY: SINGAPORE STATE: U0 ZIP: 558176 4 1 doc4.xml X0306 4 2017-01-01 0000885725 BOSTON SCIENTIFIC CORP BSX 0001538431 Bose Supratim 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 EVP & President, Asia-Pacific Common Stock 2017-01-01 4 M 0 13619.0000 0.0000 A 261672.0000 D Performance Share Units 2017-01-01 4 M 0 13619.0000 0.0000 D 2016-12-31 2016-12-31 Common Stock 13619.0000 0.0000 D On February 24, 2014, the reporting person was awarded a target number of performance share units under the Company's 2014 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2014 adjusted free cash flow measured against its 2014 financial plan over the one-year performance period ending December 31, 2014 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 23, 2015, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2016. Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock. /s/ Vance R. Brown, Attorney-in-fact 2017-01-04